VKH
ALDR

Virtu KCG Holdings’s Alder Biopharmaceuticals ALDR Stock Holding History

Virtu KCG Holdings’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$612K Buy
+53,453
New +$988K 0.02% 957
2015
Q3 		– Sell
-11,878
Closed -$629K – 4028
2015
Q2 		$629K Buy
+11,878
New +$432K 0.01% 1290

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Virtu KCG Holdings's ALDR Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Alder Biopharmaceuticals (ALDR) in Q2 2017: 53,453 shares worth $612K. The stake represents 0.02% of the portfolio and ranks #957 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in ALDR as recently as Q2 2015.

Virtu KCG Holdings first reported a position in ALDR in Q2 2015 and has held it in 2 quarters since. The position peaked at $629K in Q2 2015. 128 funds tracked by Wall St. Rank hold ALDR as of Q2 2017.

  • Virtu KCG Holdings held 53,453 shares of Alder Biopharmaceuticals worth $612K as of Q2 2017.
  • Alder Biopharmaceuticals was a new Virtu KCG Holdings position in Q2 2017.
  • Alder Biopharmaceuticals made up 0.02% of Virtu KCG Holdings's portfolio in Q2 2017, its #957 holding.
  • Virtu KCG Holdings first reported a position in Alder Biopharmaceuticals in Q2 2015 and has held it in 2 quarters since.
  • Virtu KCG Holdings's Alder Biopharmaceuticals position peaked at $629K in Q2 2015.
  • 128 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.